Concepedia

Mark Reynolds

MR

Statistics

Publications

16

Citations

1.5K

H-Index

13

Active since

1990

Affiliations

Oklahoma Department of Mental Health and Substance Abuse Services(Current)

Harvard University

Brandeis University

Loxo Oncology at Lilly (United States)

Washington Department of Social and Health Services

Mark Reynolds is an author at Oklahoma Department of Mental Health and Substance Abuse Services specializing in medicine, cancer research, and oncology.

ORCID

Top concepts

Publications per year

1990–2024

16

Publications

16

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Theodore W. Laetsch, Steven G. DuBois, Leo Mascarenhas et al. · The Lancet Oncology · 2018 · 536 citations · Full text

, , +7

The Safety of Inpatient Health Care

David W. Bates, David M. Levine, Hojjat Salmasian et al. · New England Journal of Medicine · 2023 · 329 citations · Full text

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas

Steven G. DuBois, Theodore W. Laetsch, Noah Federman et al. · Cancer · 2018 · 134 citations · Full text

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma

David S. Ziegler, Marie Wong, Chelsea Mayoh et al. · British Journal of Cancer · 2018 · 109 citations · Full text

Racial and Ethnic Differences in Substance Abuse Treatment Initiation and Engagement

Andrea Acevedo, Deborah W. Garnick, Margaret T. Lee et al. · Journal of Ethnicity in Substance Abuse · 2012 · 85 citations

, , +20

1–5 of 16